OncLive® On Air cover image

S15 Ep43: Medical Crossfire®: The Who, When, and How of TROP2-Targeting ADCs, ICIs, and PARP Inhibition in Triple-Negative Breast Cancer

OncLive® On Air

00:00

Why target TROP2 and ADC design

Heather McArthur explains TROP2 biology, ADC chemistry, high DARs, and bystander effects relevant across breast cancer subtypes.

Play episode from 05:08
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app